|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 05, 2016 )
Radiation toxicity is an illness and symptom resulting from excessive exposure to radiations. Radiation exposure can occur as a single large exposure (acute), or a series of small exposures spread over time (chronic). Exposure may be accidental or intentional (as in radiation therapy). Exposure to high amount of radiation causes degradation of DNA and other key molecular structures within cells in various tissues. The destruction of DNA ultimately affects normal replication of the cells. Exposure to smaller dose of radiation results in symptoms such as gastrointestinal disturbances including nausea and vomiting. While exposure to higher dose of radiation reflects symptoms such as neuro damage and rapid death. Unfortunately, giving first aid to radiation victims may expose rescue personnel to radiation unless they are properly protected. Thus, the increasing level of radiation toxicity that harm to human health globally has grabbed the attention of pharmaceutical companies to invest into radiation toxicity market.
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market: Drivers and Restraints
Increasing use of radiation therapy and nuclear medicine in the treatment and diagnosis of diseases is one of the major driver for the growth of radiation toxicity (radiation sickness, acute radiation syndrome) market. However, the high cost of treatment would hinder the growth of radiation toxicity (radiation sickness, acute radiation syndrome) market over the forecasted period.
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1399
RadiationToxicity (Radiation Sickness, Acute Radiation Syndrome) Market: Segmentation
The global radiation toxicity (radiation sickness/acute radiation syndrome) market is segmented based on type of radiation, disease, and drugs.
Based on radiation type, the global radiation toxicity (radiation sickness, acute radiation syndrome) market is segmented into the following:
Ionizing
Alpha
Beta
Gamma
Non-ionizing
Based on type of disease, the global radiation toxicity (radiation sickness, acute radiation syndrome) market is segmented into the following:
Bone Marrow Syndrome (Hematopoietic)
Gastrointestinal Syndrome (GI)
Cardiovascular (CV)/Central Nervous System (CNS) Syndrome
Based on type of drugs, the global radiation toxicity (radiation sickness, acute radiation syndrome) market is segmented into the following:
Antibiotics
Blood products
Colony stimulating factors
Bone marrow transplant
Stem cell transplant
Blood/platelet transfusions
RadiationToxicity(Radiation Sickness, Acute Radiation Syndrome) Market: Market Overview
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1399
The causes of radiation sickness include accidental exposure to high doses of radiation such as nuclear power plant accidents or exposure to excessive radiation for medical treatments. Bone marrow transplant may be applied when person has experienced a massive doses of radiation. Blood/platelet transfusions are generally used to treat anemia, while antibiotics to reduce the threat of infections. With the resultant increase to radiation exposure, risk of radiationtoxicity is also getting increased and thus the market for radiation toxicity (radiation sickness, acute radiation syndrome) market will grow with significant CAGR over the forecasted period.
RadiationToxicity(Radiation Sickness, Acute Radiation Syndrome) Market: Region-wiseOverlook
Currently, North America dominates the global radiation toxicity treatments market and is followed by Europe due to high level of awareness about the available radiation toxicity treatments. Asia-Pacific is also a promising market for radiation toxicity and is expected to undergo rapid market growth due to growing medical tourism industry, increase in purchasing power, rapidly improving healthcare infrastructure and increased awareness about overall healthcare and the available treatments.
RadiationToxicity (Radiation Sickness, Acute Radiation Syndrome) Market: Key Players
Key companies operational in radiation toxicity (radiation sickness, acute radiation syndrome) are Osiris Therapeutics, Inc., Nanotherapeutics, Inc., NeoStem, Inc., Gamida Cell Ltd., Cantex Pharmaceuticals, Inc., Aeolus Pharmaceuticals, Cleveland BioLabs, Inc., Piramal Enterprises Ltd., Tonix Pharmaceuticals Holding Corp., Onconova Therapeutics, Inc., and others.
Future Market Insights
Abhishek Budholiya
2076928790
abhishek.b@futuremarketinsights.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
